drugset / Trial / NCT00774306

Antiepileptic Drugs and Vascular Risk Markers

NCT00774306

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if certain seizure medications raise levels of cholesterol and other blood components which could increase the risk of heart attacks and strokes.

Timeline

Start
2009-04
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levetiracetam Other / unclassified 1000 mg
Comparator Levetiracetam Other / unclassified 1500 mg
Comparator Phenytoin Unknown 5 mg/kg
Comparator Valproate Small molecule 15 mg/kg